VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Name: VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Published: 2008
License: Public Domain

Tibotec BVBA · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

hepatitis-c hiv interaction pharmacokinetics

hepatitis c, telaprevir, hiv, vx-950-tidp24-c124, vx-950-c124, hcv, ddi, darunavir, ritonavir, fosamprenavir, interaction, pharmacokinetics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 876698
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.